SAFETY PROFILE OF OCRIPLASMIN FOR THE PHARMACOLOGIC TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION/TRACTION
Authors:
- Peter K. KaiserPKPeter K. Kaiser
- Anselm KampikAKAnselm Kampik
- Baruch D. KuppermannBKBaruch D. Kuppermann
- Aniz GirachAGAniz Girach
- Stanislao RizzoStanislao Rizzo
- Robert C. SergottRSRobert C. Sergott
Open Access
- 1 June 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 35 (6) , 1111-1127
Abstract
To report the safety of intravitreal ocriplasmin injection based on 2 Phase 3 clinical trials in patients with symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with full-thickness macular holes. Safety analyses were based on 2 completed Phase 3 studies assessing intravitreal ocriplasmin injection. Adverse events (AEs), serious AEs, and suspected adverse drug reactions are reported. The authors also report AEs of special interest from 8 other completed Phase 2 studies and 2 ongoing studies. A total of 465 eyes were injected with ocriplasmin (125 µg), and 187 eyes were treated with placebo injection in Phase 3 studies. Overall AE rate was 69.0% in the placebo group and 76.6% for ocriplasmin-treated patients. Most AEs were in the study eye, mild or moderate in severity, and transient. All suspected adverse drug reactions were ocular; the majority was nonserious, of mild intensity, and transient. Intravitreal ocriplasmin injection provides a generally well-tolerated pharmacologic treatment option for patients with symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with full-thickness macular holes ≤400 µm in diameter.Keywords
This publication has 50 references indexed in Scilit:
- The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular HoleOphthalmology, 2013
- Posterior Vitreous Detachment: Evolution and Complications of Its Early StagesAmerican Journal of Ophthalmology, 2010
- Vision-related quality of life and visual function in patients undergoing vitrectomy, gas tamponade and cataract surgery for macular holeBritish Journal of Ophthalmology, 2009
- Adult vitreous structure and postnatal changesEye, 2008
- Visual quality of life after macular hole surgery: outcome and predictive factorsBritish Journal of Ophthalmology, 2006
- Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal diseaseGraefe's Archive for Clinical and Experimental Ophthalmology, 2004
- Prospective Randomized Trial of Vitrectomy or Observation for Stage 2 Macular HolesAmerican Journal of Ophthalmology, 1996
- Course of Vitreomacular Traction SyndromeAmerican Journal of Ophthalmology, 1995
- Histopathologic Features of Idiopathic Macular Holes and CystsOphthalmology, 1990
- Posterior vitreous detachmentGraefe's Archive for Clinical and Experimental Ophthalmology, 1985